| Start Date: | 11/18/2020 | Start Time: | 4:00 PM |
| End Date: | 11/18/2020 | End Time: | 5:30 PM |
|
Event Description
BIOMED Seminar
Title:
Engineering Novel Antibody and Nanoparticle Platforms for Imaging and Therapeutic Applications
Speaker:
Andrew Tsourkas, PhD
Professor and Undergraduate Chair
Department of Bioengineering
Co-Director, Center for Targeted Therapeutics and Translational Nanomedicine (CT3N)
Institute for Translational Medicine and Therapeutics (ITMAT)
University of Pennsylvania
Details:
A major goal of my research program is to develop novel molecular imaging agents and targeted therapeutics. In particular, we are (i) developing new nanoformulations for diverse biomedical applications, including image-guided surgery, photodynamic therapy, and sonodynamic therapy; (ii) investigating new targeting strategies that maximize specificity and sensitivity or improve the accumulation and penetration of nanomaterials within tumors; and (iii) developing new bioconjugation techniques that enable the highly efficient, site-specific labeling of proteins, including antibodies. These bioconjugation tools have allowed us to pursue unique bispecific antibody applications and has enabled the efficient delivery of antibodies into the cytoplasm of living cells. We hope that these tools will help facilitate the movement towards more personalized medicine, whereby treatments are tailored to individual patients.
Biosketch:
Andrew Tsourkas, PhD, is a Professor and Undergraduate Chair of Bioengineering at the University of Pennsylvania. He received his Bachelor’s degree in Mechanical Engineering in 1997 from Cornell University and his PhD in Biomedical Engineering from the Georgia Institute of Technology/Emory University joint PhD program in 2002. He conducted a post-doctoral fellowship in the Department of Radiology at Harvard University, before joining the University of Pennsylvania in 2004.
Dr. Tsourkas is currently the Co-Director for the Center for Targeted Therapeutics and Translational Nanomedicine, as well as for the Chemical and Nanoparticle Synthesis Core. He was a recipient of the Coulter Foundation Early Career Award, the National Science Foundation CAREER Award, and was elected Fellow of the American Institute for Medical and Biological Engineering (AIMBE). |
|
Audience:
Undergraduate StudentsGraduate StudentsFacultyStaff |
|
